[{"AccountsPayableCurrent_0_Q3_USD":10418000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":96000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":339371000.0,"OtherIncome_3_Q3_USD":273000.0,"OtherIncome_1_Q3_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-11000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-43000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":5506000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":897000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":491000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":406000.0,"OperatingIncomeLoss_3_Q3_USD":-177881000.0,"OperatingIncomeLoss_1_Q3_USD":-63160000.0,"OperatingExpenses_3_Q3_USD":177881000.0,"OperatingExpenses_1_Q3_USD":63160000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"NetIncomeLoss_1_Q3_USD":-63100000.0,"PreferredStockSharesIssued_0_Q3_shares":1969797.0,"PreferredStockValue_0_Q3_USD":null,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":8000.0,"StockIssuedDuringPeriodSharesNewIssues_3_Q3_shares":1087126.0,"StockholdersEquity_0_Q3_USD":234881000.0,"ShareBasedCompensation_3_Q3_USD":20517000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":376000.0,"Revenues_3_Q3_USD":0.0,"Revenues_1_Q3_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-602761000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":152275000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":54873000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":844000.0,"ProfitLoss_3_Q3_USD":-177297000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":318769000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3812000.0,"PreferredStockSharesOutstanding_0_Q3_shares":1969797.0,"NetIncomeLoss_3_Q3_USD":-177297000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-135866000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-20698000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-4830000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":49174000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":49174000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":249970000.0,"AssetsCurrent_0_Q3_USD":302956000.0,"Assets_0_Q3_USD":304697000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":20517000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6241000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":6241000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":837636000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":4000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1711000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":58501000.0,"CommonStockSharesIssued_0_Q3_shares":16860211.0,"CommonStockSharesOutstanding_0_Q3_shares":16860211.0,"CommonStockValue_0_Q3_USD":2000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-63111000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":151734000.0,"LiabilitiesNoncurrent_0_Q3_USD":491000.0,"LiabilitiesCurrent_0_Q3_USD":69325000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":304697000.0,"Liabilities_0_Q3_USD":69816000.0,"InterestIncomeOther_3_Q3_USD":311000.0,"InterestIncomeOther_1_Q3_USD":60000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":16639776.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2799000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":9401000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":25606000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8287000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-10.84,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-3.79,"DepreciationDepletionAndAmortization_3_Q3_USD":299000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-177340000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":13279000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":16353428.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]